Nutrients

Cureus

[1] Lifestyle Intervention Framework for Obese Patients with Non-alcoholic Fatty Liver Disease - a Tool for Health Professionals in Resource Constraint Settings.

[2] Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease.

[3] rho, a fraction from rhodiola crenulate, ameliorates hepatic steatosis in mice models

[4] mtp genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients

[5] nuciferine downregulates per-arnt-sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in hepg2 cells

[6] predictors of liver fat and stiffness in non-alcoholic fatty liver disease (nafld) – an 11-year prospective study

[7] n-3 pufa status predicts non-alcoholic fatty liver disease (nafld) in older australians

[8] non-alcoholic fatty liver disease (nafld) in different populations: a clinical and epidemiological study – sample of são josé do rio preto